| Nan-ping Wang, MD PHD | |
|
747 Broadway, Seattle, WA 98122-4307 | |
| (206) 386-6000 | |
| Not Available |
| Full Name | Nan-ping Wang |
|---|---|
| Gender | Male |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 747 Broadway, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114986247 | NPI | - | NPPES |
| 203953 | Other | WA | LABOR & INDUSTRIES |
| 8360075 | Medicaid | WA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MD00032054 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Nan-ping Wang, MD PHD Po Box 3941, Seattle, WA 98124-3941 Ph: (206) 386-2676 | Nan-ping Wang, MD PHD 747 Broadway, Seattle, WA 98122-4307 Ph: (206) 386-6000 |
News Archive
Dana-Farber Cancer Institute scientists and colleagues have discovered that pancreatic cancer cells' growth and spread are fueled by an unusual metabolic pathway that someday might be blocked with targeted drugs to control the deadly cancer.
CAR T-cell therapy, which reprograms immune cells to fight cancer, has shown great promise in people with some blood cancers who have not responded to other treatments. But until now, the underlying biological pathways enabling anti-cancer responses have not been thoroughly examined.
Adding an immune checkpoint inhibitor to anti-HER2 treatment in breast cancer does not improve pathological complete response (pCR), according to the primary analysis of the IMpassion050 trial presented today during the ESMO Virtual Plenary.
Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKC), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKC in laboratory animals led to a significant decrease in pancreatic tumor growth and spread.
Chronic inflammation after a heart attack can promote heart failure and death. University of Alabama at Birmingham researchers have now shown that activated T-cells — part of the immune system's inflammatory response — are both necessary and sufficient to produce such heart failure.
› Verified 1 days ago
Afshin Shameli, MD, PHD Pathology Medicare: Medicare Enrolled Practice Location: 825 Eastlake Ave E, Seattle, WA 98109 Phone: 206-520-5000 | |
Dr. Mark Robert, Michael Kilgore, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356100, Seattle, WA 98195 Phone: 206-598-1821 Fax: 206-598-3803 | |
Corinne Lina Fligner, Pathology Medicare: Not Enrolled in Medicare Practice Location: University Of Washington Medical Ctr, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-598-6400 | |
Jennifer Lapointe, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, C212, Box 356340, Seattle, WA 98195 Phone: 206-543-0065 | |
Lee-ching Zhu, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 125 16th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Dr. Saron Ann Elizabeth Smith, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 1229 Madison St Ste 820, Seattle, WA 98104 Phone: 206-576-6507 | |
Mr. Ryuji Ohashi, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: Uwmc Pathology 1959 Ne Pacific, Box356100, Seattle, WA 98195 Phone: 206-598-7858 |